Involvement of Preformed Antifungal Compounds in the Resistance of Subtropical Fruits to Fungal Decay
Fungal pathogens must perform precise functions and overcome several barriers before they are able to initiate disease in plants. First, the pathogen must locate and adhere to suscept tissue and then initiate infection (10, 12, 14) . The first plant barriers encountered are generally the cuticle and cell wall, which may be breached by enzymatic (6) or physical (12) assault, or the pathogen may infect through wounds (27). Contact with underlying plant tissues presents the invading pathogen with a different set of barriers, most notably preformed antibiotic compounds and/ or morphologic barriers and phytoalexins induced by the plant (13, 25, 26) .
Pathogens that infect fruits are confronted by several problems not normally facing pathogens of vegetative plant tissues. Fruits are generally protected by differentiated integumentary structures, and their physiology changes markedly during development, particularly when ripening occurs. Pathogens frequently infect unripe fruits but cause relatively minor damage until ripening, when they may cause extensive decay. Such quiescent infections have been observed in tropical (l5), subtropical (8), and deciduous fruits (9). The resultant decays have great economic importance, since they reduce the shelf life of fruits during storage and transport (27) . These disease problems have been further exacerbated by the development of pathogen resistance to fungicides and the withdrawal of pesticides on environmental grounds. Consequently, there is considerable interest in determining mechanisms accounting for the natural resistance of unripe fruits to fungal pathogens and extending its effectiveness to fruits after harvest. One of the possible mechanisms that may account for such differential 
Activity of Preformed Antifungal Compounds
Critical tests of the role of preformed compounds in disease resistance are difficult, primarily because of problems in accurately assessing the quantities of inhibitory compounds that may contact an invading pathogen, uncertainty as to their in vivo biological activity, and difficulty in relating changes in their concentrations to resistance (27). The most compelling evidence for a functional role of preformed antifungal compounds in disease resistance has been produced by using genetically related pathogen strains that differ in their ability to tolerate or degrade a plant antifungal compound or barrier (2,4,5). On the other hand, simple correlations of changes in the level of a preformed compound with resistance may be serendipitous and must therefore be interpreted cautiously. However, if mechanisms accounting for the in vivo concentration of a preformed inhibitory compound are determined, then it may be possible to exogenously modulate these systems and observe whether an altered level of the inhibitory compound and disease resistance are in fact linked. For example, Holowczak et a1 (1 1) used exogenously supplied DL-phenylalanine to alter the levels of phenolic compounds and resistance of apple fruits to the scab disease. In addition to providing a critical test of whether a putative preformed resistance mechanism is physiologically important, this approach may provide treatments that can have practical uses in disease control.
In this paper we discuss the role of preformed inhibitors in fungal decays of avocado (Persea americana Miller) and mango (Mangifera indica L.). We emphasize the interaction of avocado fruit with Colletotrichum gloeosporioides (Penz.) Penz. & Sacc. in Penz. (Fig. l) , in which external modulators have been used to elucidate the nature of a preformed fungal resistance mechanism.
Preformed Antifungal Compounds in Mango Fruits
C. gloeosporioides attacks unripe mango fruits in the orchard. Germinating spores produce appressoria, but the resultant subcuticular hyphae do not develop further until fruit ripen (7). A mixture of antifungal compounds consisting of 5-12-cis-heptadecenyl resorcinol and 5-pentadecenyl resorcinol (Fig. 2) was found at fungitoxic concentrations in the peel but not in the flesh of unripe mango fruits (7, 8) . The antifungal 5-alkylated resorcinols occurred in unripe fruit of several mango cultivars at concentrations ranging between 154 and 232 pg.ml-' fresh weight but declined to levels between 74 and 125 pg.ml-' in ripe fruits when decay developed (Fig. 3) . Inhibition of germ tube elongation indicated an ED,, of approximately 120 pg.ml-', a concentration similar to that present in fruits when symptoms begin to develop.
Several lines of evidence suggested that the preformed antifungal compounds might be involved in the resistance of mango fruits to fungal development: 1) The concentration of 5-substituted resorcinols occurred at fungitoxic levels in the peel of unripe fruits of eight mango cultivars tested and decreased to nontoxic levels in uninoculated fruits at the same time that decay appeared in inoculated fruits; 2) the concentration of the 5-substituted resorcinols decreased faster during ripening in disease-susceptible cultivars than in resistant cultivars; 3) delayed reduction in levels of the antifungal compounds was related to delayed decay development; and 4) the flesh of unripe fruits contained subfungitoxic concentrations of the antifungal compounds and was susceptible to fungal attack. These observations suggested, but did not conclusively prove, that the resistance of unripe mango fruits results from fungitoxic concentrations of the antifungal 5-substituted resorcinols present in the peel acting on subcuticular hyphae from germinated appressoria. However, addi-
